
InfuSystem Holdings INFU
€ 7.81
0.0%
Quartalsbericht 2026-Q1
hinzugefügt 08.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
20.7 M |
Marktkapitalisierung |
$ 186 M |
EBITDA (LTM) |
$ 23 M |
P/E (LTM) |
31.15 |
P/S (LTM) |
1.23 |
EPS (LTM) |
0.27 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 68.62 | 2.74 % | $ 13.7 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 126.34 | 3.59 % | $ 7.23 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 426.61 | 1.91 % | $ 152 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 67.9 | 2.71 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 142.0 | 3.29 % | $ 3.5 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 113.83 | 6.15 % | $ 3.64 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.0 | 0.25 % | $ 185 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 96.59 | 1.56 % | $ 2.19 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | 0.01 % | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.82 | - | $ 83.3 M | Nasdaq Global Select Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 0.29 % | $ 32 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 67.51 | 2.24 % | $ 3.99 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 9.52 | -1.24 % | $ 80.8 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.59 | 4.91 % | $ 4.13 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 78.71 | 5.11 % | $ 3.71 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 212.88 | 1.1 % | $ 20.9 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 29.87 | -0.3 % | $ 1.48 B | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 135.75 | 3.04 % | $ 6.06 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.07 | 1.52 % | $ 221 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 334.66 | 4.66 % | $ 24.2 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.77 | 3.74 % | $ 1.74 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.47 | 2.05 % | $ 2.09 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 0.16 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 65.0 | - | $ 214 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 27.55 | 5.56 % | $ 1.32 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.85 | 2.21 % | $ 168 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.03 | 4.16 % | $ 10.3 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 196.94 | 1.97 % | $ 28.8 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.3 | 1.43 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.04 | 0.5 % | $ 268 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.34 | 3.44 % | $ 504 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 152.04 | 2.08 % | $ 43.7 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.25 | -4.13 % | $ 34.5 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.24 | 2.17 % | $ 312 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 130.13 | 3.83 % | $ 7.32 M | Nasdaq Global Select Market,SPB |